Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study

OBJECTIVE: Interferon-γ-inducible protein-10 (IP-10 or CXCL10) plays a role in inflammatory cell migration and epithelial cell survival and migration. It is expressed in higher levels in the colonic tissue and plasma of patients with ulcerative colitis (UC). This phase II study assessed the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayer, Lloyd, Sandborn, William J, Stepanov, Yuriy, Geboes, Karel, Hardi, Robert, Yellin, Michael, Tao, Xiaolu, Xu, Li An, Salter-Cid, Luisa, Gujrathi, Sheila, Aranda, Richard, Luo, Allison Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933070/
https://www.ncbi.nlm.nih.gov/pubmed/23461895
http://dx.doi.org/10.1136/gutjnl-2012-303424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933070/
https://www.ncbi.nlm.nih.gov/pubmed/23461895
http://dx.doi.org/10.1136/gutjnl-2012-303424

Ejemplares similares